Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Colon and Rectal Carcinoma market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Colon and Rectal Carcinomamarket, defines the market attractiveness level of Colon and Rectal Carcinoma market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Colon and Rectal Carcinoma industry, describes the types of Colon and Rectal Carcinoma market, the applications of major players and the market size, and deeply analyzes the current situation of the global Colon and Rectal Carcinoma market and the development prospects and opportunities of Colon and Rectal Carcinoma industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Colon and Rectal Carcinoma market in Chapter 13.
By Player:
Spectrum
Amgen
Roche
Novartis
Bayer Healthcare
Merck
Pfizer
By Type:
Colon
Rectal
By End-User:
Hospital
Clinic
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Colon and Rectal Carcinoma Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Colon and Rectal Carcinoma Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Colon and Rectal Carcinoma Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Colon and Rectal Carcinoma Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Colon and Rectal Carcinoma Market Analysis and Outlook to 2022
-
7.1 Global Colon and Rectal Carcinoma Consumption (2017-2022)
-
7.2 United States Colon and Rectal Carcinoma Consumption (2017-2022)
-
7.3 Europe Colon and Rectal Carcinoma Consumption (2017-2022)
-
7.4 China Colon and Rectal Carcinoma Consumption (2017-2022)
-
7.5 Japan Colon and Rectal Carcinoma Consumption (2017-2022)
-
7.6 India Colon and Rectal Carcinoma Consumption (2017-2022)
-
7.7 South Korea Colon and Rectal Carcinoma Consumption (2017-2022)
8 Region and Country-wise Colon and Rectal Carcinoma Market Analysis and Outlook to 2028
-
8.1 Global Colon and Rectal Carcinoma Consumption Forecast (2022-2028)
-
8.2 United States Colon and Rectal Carcinoma Consumption Forecast (2022-2028)
-
8.3 Europe Colon and Rectal Carcinoma Consumption Forecast (2022-2028)
-
8.4 China Colon and Rectal Carcinoma Consumption Forecast (2022-2028)
-
8.5 Japan Colon and Rectal Carcinoma Consumption Forecast (2022-2028)
-
8.6 India Colon and Rectal Carcinoma Consumption Forecast (2022-2028)
-
8.7 South Korea Colon and Rectal Carcinoma Consumption Forecast (2022-2028)
9 Global Colon and Rectal Carcinoma Market Outlook by Types and Applications to 2022
-
9.1 Global Colon and Rectal Carcinoma Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Colon Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Rectal Consumption and Growth Rate (2017-2022)
-
9.2 Global Colon and Rectal Carcinoma Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
10 Global Colon and Rectal Carcinoma Market Outlook by Types and Applications to 2028
-
10.1 Global Colon and Rectal Carcinoma Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Colon Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Rectal Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Colon and Rectal Carcinoma Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
11 Global Colon and Rectal Carcinoma Import and Export Analysis (Top 5 Countries)
-
11.1 Global Colon and Rectal Carcinoma Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Colon and Rectal Carcinoma Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Colon and Rectal Carcinoma Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Colon and Rectal Carcinoma Market Competitive Analysis
-
14.1 Spectrum
-
14.1.1 Spectrum Company Details
-
14.1.2 Spectrum Colon and Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Spectrum Colon and Rectal Carcinoma Product and Service
-
14.2 Amgen
-
14.2.1 Amgen Company Details
-
14.2.2 Amgen Colon and Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Amgen Colon and Rectal Carcinoma Product and Service
-
14.3 Roche
-
14.3.1 Roche Company Details
-
14.3.2 Roche Colon and Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Roche Colon and Rectal Carcinoma Product and Service
-
14.4 Novartis
-
14.4.1 Novartis Company Details
-
14.4.2 Novartis Colon and Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis Colon and Rectal Carcinoma Product and Service
-
14.5 Bayer Healthcare
-
14.5.1 Bayer Healthcare Company Details
-
14.5.2 Bayer Healthcare Colon and Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bayer Healthcare Colon and Rectal Carcinoma Product and Service
-
14.6 Merck
-
14.6.1 Merck Company Details
-
14.6.2 Merck Colon and Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Merck Colon and Rectal Carcinoma Product and Service
-
14.7 Pfizer
-
14.7.1 Pfizer Company Details
-
14.7.2 Pfizer Colon and Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Colon and Rectal Carcinoma Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Colon and Rectal Carcinoma
-
Figure Colon and Rectal Carcinoma Picture
-
Table Global Colon and Rectal Carcinoma Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Colon and Rectal Carcinoma Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Colon and Rectal Carcinoma Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Colon and Rectal Carcinoma Consumption by Country (2017-2022)
-
Figure United States Colon and Rectal Carcinoma Consumption and Growth Rate (2017-2022)
-
Table Europe Colon and Rectal Carcinoma Consumption and Growth Rate (2017-2022)
-
Figure China Colon and Rectal Carcinoma Consumption and Growth Rate (2017-2022)
-
Figure Japan Colon and Rectal Carcinoma Consumption and Growth Rate (2017-2022)
-
Figure India Colon and Rectal Carcinoma Consumption and Growth Rate (2017-2022)
-
Figure South Korea Colon and Rectal Carcinoma Consumption and Growth Rate (2017-2022)
-
Figure Global Colon and Rectal Carcinoma Consumption Forecast by Country (2022-2028)
-
Figure United States Colon and Rectal Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Colon and Rectal Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Colon and Rectal Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Colon and Rectal Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Colon and Rectal Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Colon and Rectal Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colon Consumption and Growth Rate (2017-2022)
-
Figure Global Rectal Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Colon Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rectal Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Colon and Rectal Carcinoma Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Colon and Rectal Carcinoma Export by Region (Top 5 Countries) (2017-2028)
-
Table Spectrum (Foundation Year, Company Profile and etc.)
-
Table Spectrum Colon and Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spectrum Colon and Rectal Carcinoma Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Colon and Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Colon and Rectal Carcinoma Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Colon and Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Colon and Rectal Carcinoma Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Colon and Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Colon and Rectal Carcinoma Product and Service
-
Table Bayer Healthcare (Foundation Year, Company Profile and etc.)
-
Table Bayer Healthcare Colon and Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Healthcare Colon and Rectal Carcinoma Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Colon and Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Colon and Rectal Carcinoma Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Colon and Rectal Carcinoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Colon and Rectal Carcinoma Product and Service
-
